Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$961,548
+$654,841 QoQ
Shares Held
206,785
+262.7% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 124 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0%
Shared 72%
None 28%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. AVIR ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in AVIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $961,548 | 206,785 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $306,707 | 57,009 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $866,937 | 242,840 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $762,046 | 262,775 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,294,022 | 359,451 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $910,543 | 304,530 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $732,004 | 218,509 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $742,232 | 221,562 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $844,598 | 255,166 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,414,016 | 350,004 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $958,879 | 286,233 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,432,129 | 297,740 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,297,120 | 227,965 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $626,297 | 88,211 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $637,821 | 88,341 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $635,687 | 71,106 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $714,873 | 20,390 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,511,129 | 489,345 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,616,100 | 42,366 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,784,631 | 42,715 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||